Latest filing published 03 Nov 2026 for HERON THERAPEUTICS, INC. /DE/.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -22.6%Entry US$1.37 · Close at T+365 US$1.06
- -14.5%Entry US$1.31 · Close at T+365 US$1.12
- -77.2%Entry US$2,768.00 · Close at T+365 US$632.00
- -77.4%Entry US$2,724.00 · Close at T+365 US$616.00
- +28.6%Entry US$1,680.00 · Close at T+365 US$2,160.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
William P. Forbes: trading record in brief
William P. Forbes is a declared insider at 3 companies; the most frequent names are Salix Pharmaceuticals Ltd, Heron Therapeutics, Inc. /DE/ and Beyond Air, Inc. We count 90 filings; the first trade dates from 13 July 2006 and the latest from 31 October 2026.
The open-market side counts 5 purchases for €152k alongside 23 sales for €14.1M. Sales outweigh purchases by €13.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 27 share grants and 34 option exercises.
In size, the median ticket on the buying side is €30k. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. After 5 purchases with a full 90-day history, the hit rate stands at 60% and the median 90-day move at +40.0%. These figures describe past trades and do not predict future prices.
The record was last updated on 3 November 2026 with an option exercise in Heron Therapeutics, Inc. /DE/. The last insider purchase was made public on 21 November 2023, 1,083 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to William P. Forbes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,770 sharesCommon StockSEC:0001193125-26-444842:0
- 3,349 shares@ US$0.28Common StockSEC:0001193125-26-444842:1
- 11,695 sharesCommon StockSEC:0001193125-26-444842:2
- 3,327 shares@ US$0.28Common StockSEC:0001193125-26-444842:3
- 3,874 sharesCommon StockSEC:0001193125-26-427542:0
- 1,102 shares@ US$0.360.0006% mcap0.5% of flowCommon StockSEC:0001193125-26-427542:1
- 11,769 sharesCommon StockSEC:0001193125-26-329804:0
- 11,694 sharesCommon StockSEC:0001193125-26-329804:2
- 3,348 shares@ US$0.500.0030% mcap2.0% of flowCommon StockSEC:0001193125-26-329804:1
- 3,326 shares@ US$0.500.0030% mcap2.0% of flowCommon StockSEC:0001193125-26-329804:3
- 1,101 shares@ US$0.470.0009% mcap0.6% of flowCommon StockSEC:0001193125-26-308922:1
- 3,874 sharesCommon StockSEC:0001193125-26-308922:0
- 3,874 sharesCommon StockSEC:0001193125-26-165591:0
- 11,695 sharesCommon StockSEC:0001193125-26-034491:0
- 3,875 sharesCommon StockSEC:0001193125-26-016451:0
- 11,694 sharesCommon StockSEC:0001193125-25-264044:0
- 3,874 sharesCommon StockSEC:0001193125-25-244582:0
- 11,695 sharesCommon StockSEC:0000950170-25-102161:0
- 3,874 sharesCommon StockSEC:0000950170-25-097503:0
- 12,500 sharesCommon StockSEC:0000950170-25-084006:0
- 11,694 sharesCommon StockSEC:0000950170-25-063065:0
- 3,875 sharesCommon StockSEC:0000950170-25-056495:0
- 3,874 sharesCommon StockSEC:0000950170-25-007549:0
- 3,874 sharesCommon StockSEC:0000950170-24-115925:0
- 3,875 sharesCommon StockSEC:0000950170-24-085092:0
25 of 90 declarations